Physician profile
Melissa A Merhege
NPI 1003111873
$5,287.93
in general payments reported to CMS, 2019-2025
19 companies · $982 in 2025
The $982 reported for 2025 was more than what a typical Pain Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $159 · 2021: $334 · 2022: $1,753 · 2023: $537 · 2024: $1,282 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,800.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,321.32 | 2019-2024 | Senza |
| Abbott Laboratories | $518.83 | 2019-2025 | Proclaim, Eterna |
| Globus Medical, INC. | $394.24 | 2025 | Senza |
| Medtronic, INC. | $269.03 | 2024-2025 | Kyphon Express II Kyphopak Tray, Accurian, Intellis Adaptivestim |
| Abbvie INC. | $265.37 | 2023-2025 | |
| Pfizer INC. | $82.17 | 2023-2025 | |
| Merz Pharmaceuticals, LLC | $74.92 | 2023 | Xeomin |
| Alkermes, INC. | $58.22 | 2019 | |
| Lundbeck LLC | $56.81 | 2023-2025 | Vyepti |
| Vertex Pharmaceuticals Incorporated | $48.31 | 2024-2025 | |
| Nalu Medical, INC. | $33.81 | 2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $26.78 | 2024 | Sprint Pns System |
| Bioventus LLC | $25.26 | 2025 | Xcell |
| Boston Scientific Corporation | $23.24 | 2019 | |
| Allergan, INC. | $22.19 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stratus Medical, LLC | $20.94 | 2022 | |
| Vertos Medical, INC. | $18.74 | 2023 | Mild Device Kit |
| Teva Pharmaceuticals USA, INC. | $14.38 | 2024 | Ajovy |
| Sunovion Pharmaceuticals INC. | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Merhege listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.